word,tfidf
month,0.7259563175873341
week,0.27094096183458904
12,0.2568084057120119
24,0.15888865389376278
response,0.13671814404812144
criteria,0.10134432923583865
disease,0.09976729430538593
adverse,0.09052958186970204
score,0.07859356144820141
rate,0.07390169948547107
events,0.07390169948547107
grade,0.06835907202406072
cells,0.06835907202406072
48,0.06618405174585382
16,0.06618405174585382
baseline,0.06411580012879588
incidence,0.06411580012879588
assessed,0.0628164445626504
relapse,0.059121359588376846
graft,0.059121359588376846
inclusion,0.057273817101240077
days,0.055426274614103294
infusion,0.05357873212696652
severe,0.05357873212696652
following,0.051731189639829735
survival,0.049883647152692966
estimated,0.048783873784378484
safety,0.04803610466555619
life,0.04803610466555619
versus,0.04803610466555619
remission,0.04803610466555619
host,0.04803610466555619
trsae,0.04789151968096931
endpoint,0.04756978719233243
evaluated,0.04756978719233243
complete,0.046188562178419414
primary,0.046188562178419414
quality,0.046188562178419414
compared,0.0455015355752745
25,0.0455015355752745
36,0.0455015355752745
priors,0.045093348322148535
overall,0.04434101969128263
analysis,0.04434101969128263
cell,0.042493477204145855
progression,0.042493477204145855
capacity,0.04199030731853266
informative,0.04199030731853266
21,0.0418147489580387
imaging,0.04136503234115864
hospitalization,0.04136503234115864
health,0.04064593471700908
post,0.04064593471700908
event,0.04064593471700908
22,0.03716866574047885
common,0.03716866574047885
terminology,0.03716866574047885
improvement,0.03716866574047885
bilag,0.03674151890371608
changes,0.03674151890371608
questionnaire,0.03674151890371608
100,0.03516027748998484
skin,0.03516027748998484
transplantation,0.03510330725559875
resonance,0.03484562413169892
magnetic,0.03484562413169892
beta,0.03484562413169892
rodnan,0.034117124696307795
toxicity,0.033255764768461975
20,0.033255764768461975
arm,0.033255764768461975
lesions,0.033255764768461975
cdeis,0.0329254197806664
acute,0.0314082222813252
best,0.0314082222813252
prednisone,0.031023774255868976
mean,0.031023774255868976
analyses,0.03019954091413906
troubles,0.029932199800605817
normalization,0.029932199800605817
weeks,0.029560679794188423
failure,0.029560679794188423
mesenchymal,0.028955522638811043
function,0.028955522638811043
stromal,0.028955522638811043
proteinuria,0.028868336281491207
models,0.027876499305359133
cardiac,0.027713137307051647
30,0.027713137307051647
disappearance,0.026938979820545234
free,0.02688727102175311
central,0.02688727102175311
parameters,0.02688727102175311
endpoints,0.02688727102175311
actg,0.026243942074082916
prevalence,0.026243942074082916
modified,0.025865594819914867
systemic,0.025865594819914867
follow,0.025865594819914867
lung,0.025553457696579206
efficacy,0.02481901940469518
occurrence,0.02481901940469518
evaluation,0.02481901940469518
estimator,0.024281033711926133
ileocolonoscopies,0.024281033711926133
chronic,0.024018052332778095
transplant,0.024018052332778095
model,0.024018052332778095
increase,0.024018052332778095
secondary,0.024018052332778095
injection,0.024018052332778095
diffusing,0.023945759840484655
carbon,0.023945759840484655
reappearance,0.023945759840484655
monoxide,0.023945759840484655
bayesian,0.023619547866674626
ventricular,0.023619547866674626
pga,0.023619547866674626
clinically,0.02323041608779928
repeated,0.02323041608779928
platelets,0.02323041608779928
creatinine,0.02323041608779928
cancer,0.02275076778763725
infusions,0.02275076778763725
assessment,0.022170509845641315
cost,0.02099515365926633
equal,0.02099515365926633
forced,0.02099515365926633
uniform,0.02095253986042407
grading,0.02095253986042407
worsening,0.02090737447901935
arms,0.02090737447901935
consecutive,0.02090737447901935
phd,0.020812314610222402
appearance,0.020812314610222402
credible,0.020812314610222402
v5,0.020812314610222402
normal,0.02068251617057932
change,0.02068251617057932
sclerosis,0.02068251617057932
effect,0.02068251617057932
percentage,0.02068251617057932
vasculitis,0.02032296735850454
retinal,0.02032296735850454
eye,0.02032296735850454
55,0.02032296735850454
considered,0.02032296735850454
10,0.02032296735850454
classification,0.018614264553521387
index,0.018614264553521387
vascular,0.018614264553521387
composite,0.018614264553521387
partial,0.018614264553521387
decrease,0.018614264553521387
hours,0.018584332870239424
cumulative,0.018584332870239424
measured,0.018584332870239424
left,0.018584332870239424
nervous,0.018584332870239424
protein,0.018584332870239424
reactive,0.018584332870239424
vital,0.018584332870239424
described,0.018584332870239424
milligrams,0.018475424871367767
data,0.018475424871367767
early,0.018475424871367767
count,0.018475424871367767
treatments,0.018475424871367767
end,0.018475424871367767
anti,0.018475424871367767
binomial,0.01837075945185804
sf,0.01837075945185804
scleroderma,0.01795931988036349
density,0.01795931988036349
alive,0.01795931988036349
linear,0.017343595508518668
biologically,0.017343595508518668
reading,0.017343595508518668
impairment,0.017343595508518668
uveitis,0.016627882384230987
levels,0.016627882384230987
red,0.016627882384230987
60,0.016627882384230987
specific,0.016627882384230987
chimerism,0.016627882384230987
involvement,0.016627882384230987
date,0.016627882384230987
activity,0.016627882384230987
serum,0.016546012936463454
tumor,0.016546012936463454
appendix,0.016546012936463454
neutrophils,0.016546012936463454
monitoring,0.016546012936463454
laboratory,0.016546012936463454
visit,0.016546012936463454
stopping,0.016261291261459497
maximum,0.016261291261459497
renal,0.016261291261459497
analyzed,0.016261291261459497
markers,0.01574636524444975
rank,0.01574636524444975
glomerular,0.01574636524444975
ct,0.01574636524444975
random,0.01574636524444975
scan,0.01574636524444975
abnormalities,0.014966099900302909
segmental,0.014966099900302909
thickness,0.014966099900302909
filtration,0.014966099900302909
centralized,0.014966099900302909
kaplan,0.014966099900302909
meier,0.014966099900302909
immune,0.014780339897094211
randomization,0.014780339897094211
year,0.014780339897094211
therapy,0.014780339897094211
probability,0.014780339897094211
19,0.014780339897094211
level,0.014780339897094211
independent,0.014780339897094211
ii,0.014780339897094211
increased,0.014780339897094211
status,0.014477761319405522
nk,0.014477761319405522
engraftment,0.014477761319405522
haze,0.014477761319405522
proportion,0.014477761319405522
transfusion,0.014477761319405522
visual,0.014477761319405522
recorded,0.013938249652679566
lymphocytes,0.013938249652679566
expression,0.013938249652679566
coherence,0.013938249652679566
tomography,0.013938249652679566
flare,0.013938249652679566
documented,0.013938249652679566
national,0.013938249652679566
observations,0.013938249652679566
criterion,0.013938249652679566
optical,0.013938249652679566
occurs,0.013938249652679566
pcr,0.013938249652679566
account,0.013938249652679566
section,0.013938249652679566
measurements,0.013874876406814934
organization,0.013874876406814934
unblinded,0.013874876406814934
scales,0.013874876406814934
recist,0.013874876406814934
rule,0.013121971037041458
definition,0.013121971037041458
prednisolone,0.013121971037041458
rejection,0.013121971037041458
organs,0.013121971037041458
intervals,0.013121971037041458
severity,0.012932797409957434
phase,0.012932797409957434
resolution,0.012932797409957434
measures,0.012932797409957434
intravenous,0.012932797409957434
hematopoietic,0.012932797409957434
randomized,0.01240950970234759
cause,0.01240950970234759
requiring,0.01240950970234759
start,0.01240950970234759
absence,0.01240950970234759
neutrophil,0.01240950970234759
gastrointestinal,0.011972879920242327
globally,0.011972879920242327
anonymous,0.011972879920242327
stabilization,0.011972879920242327
toxic,0.011972879920242327
24h,0.011972879920242327
ctae,0.011972879920242327
nih,0.011972879920242327
mcr,0.011972879920242327
md,0.011972879920242327
attacks,0.011972879920242327
mdrd,0.011972879920242327
magic,0.011972879920242327
adjusted,0.011972879920242327
acuity,0.01161520804389964
corrected,0.01161520804389964
reconstitution,0.01161520804389964
blinded,0.01161520804389964
gamma,0.01161520804389964
endoscopic,0.01161520804389964
dna,0.01161520804389964
target,0.01161520804389964
clearance,0.01161520804389964
institute,0.01161520804389964
absolute,0.01161520804389964
evolution,0.011085254922820658
second,0.011085254922820658
kilograms,0.011085254922820658
steroids,0.011085254922820658
infections,0.011085254922820658
samples,0.011085254922820658
corticosteroid,0.011085254922820658
value,0.011085254922820658
active,0.011085254922820658
death,0.011085254922820658
pre,0.011085254922820658
borr,0.010497576829633166
min,0.010497576829633166
physician,0.010497576829633166
women,0.010497576829633166
features,0.010497576829633166
tested,0.010497576829633166
tolerability,0.010497576829633166
world,0.010497576829633166
physical,0.010497576829633166
degree,0.010497576829633166
cd4,0.010497576829633166
cd8,0.010497576829633166
ferritin,0.010497576829633166
digestive,0.010497576829633166
distribution,0.010497576829633166
stenosis,0.010497576829633166
segment,0.010497576829633166
chest,0.010497576829633166
survey,0.010497576829633166
47,0.010406157305111201
ulcerations,0.010406157305111201
addenda,0.010406157305111201
manifestation,0.010406157305111201
leukemic,0.010406157305111201
conclude,0.010406157305111201
10000,0.010406157305111201
consortium,0.010406157305111201
intercept,0.010406157305111201
distributions,0.010406157305111201
platelet,0.01034125808528966
transfusions,0.01034125808528966
point,0.01034125808528966
antibiotic,0.01034125808528966
body,0.01034125808528966
ks,0.01034125808528966
bd,0.01034125808528966
mortality,0.01034125808528966
use,0.01034125808528966
interaction,0.01034125808528966
confirmed,0.01034125808528966
included,0.01034125808528966
tolerance,0.01034125808528966
scale,0.01034125808528966
symptoms,0.01034125808528966
lymphocyte,0.009292166435119712
beginning,0.009292166435119712
biological,0.009292166435119712
reduced,0.009292166435119712
decreased,0.009292166435119712
toxicities,0.009292166435119712
moderate,0.009292166435119712
global,0.009292166435119712
chosen,0.009292166435119712
95,0.009292166435119712
surface,0.009292166435119712
hemolytic,0.009292166435119712
cerebral,0.009292166435119712
scores,0.009292166435119712
cd,0.009292166435119712
kidney,0.009292166435119712
tolerated,0.009292166435119712
du,0.009292166435119712
white,0.009292166435119712
pulmonary,0.009292166435119712
13,0.009292166435119712
discontinuation,0.009292166435119712
difference,0.009292166435119712
observed,0.009237712435683883
behcets,0.009237712435683883
syndrome,0.009237712435683883
50,0.009237712435683883
infection,0.009237712435683883
posterior,0.009237712435683883
peripheral,0.009237712435683883
period,0.009237712435683883
medical,0.009237712435683883
test,0.009237712435683883
vitreous,0.009237712435683883
stem,0.009237712435683883
collection,0.009237712435683883
analyzing,0.008979659940181744
percent,0.008979659940181744
market,0.008979659940181744
log,0.008979659940181744
preinclusion,0.008979659940181744
short,0.008979659940181744
stock,0.008979659940181744
exam,0.008979659940181744
achieving,0.008979659940181744
epi,0.008979659940181744
abdominal,0.008979659940181744
5d,0.008979659940181744
ckd,0.008979659940181744
delay,0.008979659940181744
budesonide,0.008979659940181744
36v2,0.008979659940181744
titers,0.008979659940181744
eq,0.008979659940181744
aes,0.008979659940181744
il,0.008979659940181744
troponin,0.008979659940181744
pains,0.008979659940181744
mra,0.008979659940181744
previous,0.008273006468231727
usual,0.008273006468231727
need,0.008273006468231727
course,0.008273006468231727
nomenclature,0.008273006468231727
allogeneic,0.008273006468231727
considering,0.008273006468231727
different,0.008273006468231727
international,0.008273006468231727
collected,0.008273006468231727
sparing,0.008273006468231727
frequency,0.008273006468231727
covid,0.008273006468231727
18,0.008273006468231727
standardization,0.008273006468231727
visits,0.008273006468231727
presence,0.008273006468231727
rules,0.007873182622224875
5l,0.007873182622224875
targets,0.007873182622224875
sub,0.007873182622224875
cmv,0.007873182622224875
clinic,0.007873182622224875
creatininuria,0.007873182622224875
recurrence,0.007873182622224875
board,0.007873182622224875
discretion,0.007873182622224875
quantification,0.007873182622224875
curve,0.007873182622224875
myeloid,0.007873182622224875
detection,0.007873182622224875
numbers,0.007873182622224875
neutropenia,0.007873182622224875
pain,0.007873182622224875
microns,0.007873182622224875
ctc,0.007873182622224875
echocardiography,0.007873182622224875
continuous,0.007873182622224875
mass,0.007873182622224875
arthritis,0.007873182622224875
preexisting,0.007873182622224875
rates,0.007390169948547106
ocular,0.007390169948547106
associated,0.007390169948547106
duration,0.007390169948547106
refractory,0.007390169948547106
care,0.007390169948547106
donor,0.007390169948547106
plasma,0.007390169948547106
concentration,0.007390169948547106
macular,0.007390169948547106
interval,0.007390169948547106
final,0.006969124826339783
cure,0.006969124826339783
define,0.006969124826339783
weight,0.006969124826339783
300,0.006969124826339783
objective,0.006969124826339783
allo,0.006969124826339783
immunological,0.006969124826339783
180,0.006969124826339783
voc,0.006969124826339783
version,0.006969124826339783
santé,0.006969124826339783
ebv,0.006969124826339783
values,0.006969124826339783
meeting,0.006969124826339783
unacceptable,0.006969124826339783
cycle,0.006969124826339783
bone,0.006969124826339783
interim,0.006969124826339783
positive,0.006969124826339783
biopsy,0.006969124826339783
treat,0.006969124826339783
underlying,0.006969124826339783
deterioration,0.006969124826339783
lower,0.006969124826339783
reasons,0.006969124826339783
real,0.006969124826339783
profile,0.006969124826339783
impact,0.006969124826339783
respectively,0.006969124826339783
virological,0.006969124826339783
extra,0.006969124826339783
set,0.006969124826339783
initiation,0.006969124826339783
grfs,0.006969124826339783
sample,0.006969124826339783
avoided,0.006937438203407467
ulcers,0.006937438203407467
triggered,0.006937438203407467
osseous,0.006937438203407467
ctep,0.006937438203407467
neurologic,0.006937438203407467
10mg,0.006937438203407467
novo,0.006937438203407467
nephritis,0.006937438203407467
ophthalmological,0.006937438203407467
miller,0.006937438203407467
osteoporosis,0.006937438203407467
diet,0.006937438203407467
doubling,0.006937438203407467
doubled,0.006937438203407467
territory,0.006937438203407467
rectal,0.006937438203407467
lasting,0.006937438203407467
jy,0.006937438203407467
diseappearance,0.006937438203407467
productivity,0.006937438203407467
38,0.006937438203407467
214,0.006937438203407467
207,0.006937438203407467
mast,0.006937438203407467
correlations,0.006937438203407467
articular,0.006937438203407467
logistic,0.006937438203407467
dysfunctions,0.006937438203407467
surrogate,0.006937438203407467
gammaglobulines,0.006937438203407467
endocrinal,0.006937438203407467
gained,0.006937438203407467
seen,0.006937438203407467
hematuria,0.006937438203407467
remissions,0.006937438203407467
aggravation,0.006937438203407467
dysmetabolic,0.006937438203407467
ekg,0.006937438203407467
estimations,0.006937438203407467
superficial,0.006937438203407467
1g,0.006937438203407467
covid19,0.006937438203407467
140,0.006937438203407467
1981,0.006937438203407467
neurological,0.006204754851173795
organ,0.006204754851173795
uninjected,0.006204754851173795
stage,0.006204754851173795
onset,0.006204754851173795
sle,0.006204754851173795
right,0.006204754851173795
antibodies,0.006204754851173795
antigen,0.006204754851173795
injected,0.006204754851173795
inflammatory,0.006204754851173795
hospital,0.006204754851173795
chamber,0.006204754851173795
calculated,0.006204754851173795
sct,0.006204754851173795
leukocyte,0.006204754851173795
presented,0.006204754851173795
effects,0.006204754851173795
reduction,0.006204754851173795
counts,0.006204754851173795
inflammation,0.006204754851173795
investigator,0.006204754851173795
manifestations,0.006204754851173795
low,0.006204754851173795
2016,0.006204754851173795
follows,0.006204754851173795
tyndall,0.005986439960121164
muscular,0.005986439960121164
multi,0.005986439960121164
excluding,0.005986439960121164
orr,0.005986439960121164
tricuspid,0.005986439960121164
finally,0.005986439960121164
nationale,0.005986439960121164
standards,0.005986439960121164
cytometry,0.005986439960121164
deep,0.005986439960121164
neuropathy,0.005986439960121164
angio,0.005986439960121164
gt,0.005986439960121164
produits,0.005986439960121164
thoracic,0.005986439960121164
hospitalized,0.005986439960121164
rennes,0.005986439960121164
sécurité,0.005986439960121164
conseil,0.005986439960121164
cardiovascular,0.005986439960121164
velocity,0.005986439960121164
courses,0.005986439960121164
neoplasia,0.005986439960121164
ileocolonoscopy,0.005986439960121164
dyslipidemia,0.005986439960121164
censored,0.005986439960121164
electrolytes,0.005986439960121164
lethargy,0.005986439960121164
intent,0.005986439960121164
agence,0.005986439960121164
medicament,0.005986439960121164
med,0.005986439960121164
populations,0.005986439960121164
gadolinium,0.005986439960121164
segments,0.005986439960121164
bn,0.005986439960121164
collaboration,0.005986439960121164
blinding,0.005986439960121164
accompanied,0.005986439960121164
equation,0.005986439960121164
lvef,0.005986439960121164
copies,0.005986439960121164
siti,0.005986439960121164
episode,0.005986439960121164
enhancement,0.005986439960121164
aplasia,0.005986439960121164
quantitative,0.005986439960121164
c2d1,0.005986439960121164
tnfa,0.005986439960121164
scored,0.005986439960121164
result,0.005986439960121164
esr,0.005986439960121164
lymphedema,0.005986439960121164
amplification,0.005542627461410329
cryoglobulinemia,0.005542627461410329
edema,0.005542627461410329
sars,0.005542627461410329
treated,0.005542627461410329
main,0.005542627461410329
unit,0.005542627461410329
daily,0.005542627461410329
evidence,0.005542627461410329
human,0.005542627461410329
potential,0.005542627461410329
total,0.005542627461410329
previously,0.005542627461410329
anterior,0.005542627461410329
prca,0.005542627461410329
unique,0.005248788414816583
urine,0.005248788414816583
v3,0.005248788414816583
stored,0.005248788414816583
statistics,0.005248788414816583
average,0.005248788414816583
ms,0.005248788414816583
paraclinical,0.005248788414816583
description,0.005248788414816583
sri,0.005248788414816583
sponsor,0.005248788414816583
extensive,0.005248788414816583
men,0.005248788414816583
metabolic,0.005248788414816583
mild,0.005248788414816583
complement,0.005248788414816583
epidemiology,0.005248788414816583
length,0.005248788414816583
sequentially,0.005248788414816583
adherence,0.005248788414816583
gov,0.005248788414816583
check,0.005248788414816583
chelation,0.005248788414816583
250,0.005248788414816583
bilateral,0.005248788414816583
maintenance,0.005248788414816583
phosphatase,0.005248788414816583
clinical,0.005248788414816583
transferase,0.005248788414816583
bilirubin,0.005248788414816583
sign,0.005248788414816583
acquired,0.005248788414816583
acr,0.005248788414816583
fertility,0.005248788414816583
gammaglobulin,0.005248788414816583
enzymes,0.005248788414816583
eortc,0.005248788414816583
diffuse,0.005248788414816583
fever,0.005248788414816583
c30,0.005248788414816583
c4,0.005248788414816583
keytruda,0.005248788414816583
leakage,0.005248788414816583
cervical,0.005248788414816583
qlq,0.005248788414816583
affected,0.005248788414816583
provisional,0.005248788414816583
doppler,0.005248788414816583
angiography,0.005248788414816583
haut,0.005248788414816583
safe,0.005248788414816583
consider,0.005248788414816583
tests,0.005248788414816583
diabetes,0.005248788414816583
alkaline,0.005248788414816583
questionnaires,0.005248788414816583
hemoglobin,0.005248788414816583
hhv8,0.005248788414816583
reactants,0.005248788414816583
infiltration,0.005248788414816583
tarte,0.005248788414816583
radiological,0.005248788414816583
amino,0.005248788414816583
immunosuppression,0.005248788414816583
reaction,0.005248788414816583
effectiveness,0.005248788414816583
whichever,0.005248788414816583
volume,0.005248788414816583
assay,0.005248788414816583
zero,0.005248788414816583
150,0.005248788414816583
combined,0.004646083217559856
modification,0.004646083217559856
causes,0.004646083217559856
recipient,0.004646083217559856
recommendation,0.004646083217559856
05,0.004646083217559856
fact,0.004646083217559856
stroke,0.004646083217559856
estimate,0.004646083217559856
29,0.004646083217559856
measurement,0.004646083217559856
acs,0.004646083217559856
sledai,0.004646083217559856
performans,0.004646083217559856
better,0.004646083217559856
500,0.004646083217559856
determined,0.004646083217559856
consumption,0.004646083217559856
area,0.004646083217559856
regression,0.004646083217559856
ecog,0.004646083217559856
search,0.004646083217559856
gene,0.004646083217559856
selena,0.004646083217559856
enrolled,0.004646083217559856
disorders,0.004646083217559856
activation,0.004646083217559856
charge,0.004646083217559856
la,0.004646083217559856
judgment,0.004646083217559856
candidate,0.004646083217559856
responders,0.004646083217559856
hematological,0.004646083217559856
injections,0.004646083217559856
allograft,0.004646083217559856
table,0.004646083217559856
relapses,0.004646083217559856
identification,0.004646083217559856
immunosuppressive,0.004646083217559856
implemented,0.004646083217559856
expected,0.004646083217559856
ml,0.004646083217559856
mmol,0.004646083217559856
negative,0.004646083217559856
cytokines,0.004646083217559856
cov,0.004646083217559856
01,0.004646083217559856
17,0.0041365032341158636
cutaneous,0.0041365032341158636
aiec,0.0041365032341158636
intensive,0.0041365032341158636
required,0.0041365032341158636
allow,0.0041365032341158636
taken,0.0041365032341158636
antibody,0.0041365032341158636
anemia,0.0041365032341158636
investigators,0.0041365032341158636
heart,0.0041365032341158636
thrombosis,0.0041365032341158636
marrow,0.0041365032341158636
corticosteroids,0.0041365032341158636
approach,0.0041365032341158636
line,0.0041365032341158636
liver,0.0041365032341158636
loss,0.0041365032341158636
limited,0.0041365032341158636
points,0.0041365032341158636
present,0.0041365032341158636
ensure,0.0041365032341158636
45,0.0041365032341158636
regulatory,0.0041365032341158636
reference,0.0041365032341158636
iii,0.0041365032341158636
pembrolizumab,0.0041365032341158636
biopsies,0.0041365032341158636
des,0.0041365032341158636
measure,0.0041365032341158636
paris,0.0041365032341158636
assess,0.0041365032341158636
terms,0.0041365032341158636
committee,0.0041365032341158636
costs,0.0041365032341158636
refer,0.0041365032341158636
support,0.0041365032341158636
factors,0.0041365032341158636
viral,0.0041365032341158636
performance,0.0041365032341158636
perform,0.0041365032341158636
adapted,0.003695084974273553
placebo,0.003695084974273553
additional,0.003695084974273553
greater,0.003695084974273553
capmatinib,0.003695084974273553
administration,0.003695084974273553
steroid,0.003695084974273553
step,0.003695084974273553
complications,0.003695084974273553
vessel,0.003695084974273553
includes,0.003695084974273553
optimal,0.003695084974273553
doses,0.003695084974273553
et,0.003695084974273553
group,0.003695084974273553
current,0.003695084974273553
mo,0.0034687191017037334
declared,0.0034687191017037334
occurence,0.0034687191017037334
ctc_50,0.0034687191017037334
cylinders,0.0034687191017037334
1999,0.0034687191017037334
morality,0.0034687191017037334
necessarily,0.0034687191017037334
banked,0.0034687191017037334
avascular,0.0034687191017037334
cytotoxicity,0.0034687191017037334
cytology,0.0034687191017037334
indicative,0.0034687191017037334
explicit,0.0034687191017037334
quantity,0.0034687191017037334
alloantibodies,0.0034687191017037334
electronic_applications,0.0034687191017037334
quantified,0.0034687191017037334
jb,0.0034687191017037334
histological,0.0034687191017037334
john,0.0034687191017037334
jet,0.0034687191017037334
amh,0.0034687191017037334
cd3,0.0034687191017037334
montparnasse,0.0034687191017037334
variance,0.0034687191017037334
mrt,0.0034687191017037334
unlikely,0.0034687191017037334
variation,0.0034687191017037334
vd,0.0034687191017037334
sclicc,0.0034687191017037334
kit,0.0034687191017037334
jp,0.0034687191017037334
bsas,0.0034687191017037334
calprotectin,0.0034687191017037334
california,0.0034687191017037334
reticulocytopenia,0.0034687191017037334
prob,0.0034687191017037334
height,0.0034687191017037334
gut,0.0034687191017037334
revised,0.0034687191017037334
aom,0.0034687191017037334
annexe,0.0034687191017037334
annals,0.0034687191017037334
rouge,0.0034687191017037334
roth,0.0034687191017037334
dhtr,0.0034687191017037334
protocoldevelopment,0.0034687191017037334
przepiorka,0.0034687191017037334
doesnt,0.0034687191017037334
qql,0.0034687191017037334
dlqi,0.0034687191017037334
tmax,0.0034687191017037334
tm,0.0034687191017037334
hemoglobinuria,0.0034687191017037334
hermine,0.0034687191017037334
residence,0.0034687191017037334
albumin,0.0034687191017037334
chain,0.0034687191017037334
centered,0.0034687191017037334
inverse,0.0034687191017037334
qualified,0.0034687191017037334
indices,0.0034687191017037334
imputable,0.0034687191017037334
experiencing,0.0034687191017037334
regurgitation,0.0034687191017037334
htm,0.0034687191017037334
cd56,0.0034687191017037334
fracture,0.0034687191017037334
polymerase,0.0034687191017037334
location,0.0034687191017037334
immunoglobulin,0.0034687191017037334
regurgitant,0.0034687191017037334
regress,0.0034687191017037334
75015,0.0034687191017037334
cardiological,0.0034687191017037334
bosch,0.0034687191017037334
bonne,0.0034687191017037334
carriage,0.0034687191017037334
accurate,0.0034687191017037334
fitting,0.0034687191017037334
foster,0.0034687191017037334
discussion,0.0034687191017037334
36v2tm,0.0034687191017037334
globule,0.0034687191017037334
dialysis,0.0034687191017037334
gobal,0.0034687191017037334
practices,0.0034687191017037334
dimension,0.0034687191017037334
adding,0.0034687191017037334
kdigo2012,0.0034687191017037334
characterization,0.0034687191017037334
adjudicated,0.0034687191017037334
chevret,0.0034687191017037334
cmax,0.0034687191017037334
colitis,0.0034687191017037334
sf36v2,0.0034687191017037334
sh,0.0034687191017037334
simultaneously,0.0034687191017037334
specify,0.0034687191017037334
aphtoid,0.0034687191017037334
mar,0.0034687191017037334
arthralgia,0.0034687191017037334
transcripts,0.0034687191017037334
52,0.0034687191017037334
ileitis,0.0034687191017037334
imagine,0.0034687191017037334
absolue,0.0034687191017037334
73,0.0034687191017037334
luminex,0.0034687191017037334
economic,0.0034687191017037334
99,0.0034687191017037334
dermatology,0.0034687191017037334
panels,0.0034687191017037334
million,0.0034687191017037334
methodology,0.0034687191017037334
patientsfiles,0.0034687191017037334
densities,0.0034687191017037334
paxgene,0.0034687191017037334
pbmcs,0.0034687191017037334
pdl1,0.0034687191017037334
ped,0.0034687191017037334
mediator,0.0034687191017037334
cl,0.0034687191017037334
city,0.0034687191017037334
circumference,0.0034687191017037334
ordinal,0.0034687191017037334
false,0.0034687191017037334
far,0.0034687191017037334
strips,0.0034687191017037334
supervisor,0.0034687191017037334
subset,0.0034687191017037334
medullary,0.0034687191017037334
establish,0.0034687191017037334
painful,0.0034687191017037334
packed,0.0034687191017037334
echocardiographies,0.0034687191017037334
eac,0.0034687191017037334
dyspnea,0.0034687191017037334
105,0.0034687191017037334
107,0.0034687191017037334
1b,0.0034687191017037334
oliguria,0.0034687191017037334
oozing,0.0034687191017037334
optimizing,0.0034687191017037334
recall,0.0034687191017037334
telomere,0.0034687191017037334
veino,0.0034687191017037334
zhang,0.0034687191017037334
bdca,0.0034687191017037334
attributable,0.0034687191017037334
130,0.0034687191017037334
2007,0.0034687191017037334
aspects,0.0034687191017037334
exhaustion,0.0034687191017037334
cytof,0.0034687191017037334
excellence,0.0034687191017037334
vincent,0.0034687191017037334
vfq,0.002993219980060582
crt,0.002993219980060582
van,0.002993219980060582
fsh,0.002993219980060582
film,0.002993219980060582
settings,0.002993219980060582
gastrectomy,0.002993219980060582
gastroenterology,0.002993219980060582
glomerulonephritis,0.002993219980060582
accordingly,0.002993219980060582
negativation,0.002993219980060582
nerve,0.002993219980060582
aseptic,0.002993219980060582
aspiration,0.002993219980060582
auricular,0.002993219980060582
moment,0.002993219980060582
mononeuropathy,0.002993219980060582
designs,0.002993219980060582
desire,0.002993219980060582
ovarian,0.002993219980060582
pancytopenia,0.002993219980060582
mos,0.002993219980060582
myelitis,0.002993219980060582
mmhg,0.002993219980060582
oestrogen,0.002993219980060582
olivier,0.002993219980060582
accounting,0.002993219980060582
fluorescein,0.002993219980060582
schemes,0.002993219980060582
scientific,0.002993219980060582
fulfilled,0.002993219980060582
functioning,0.002993219980060582
snellen,0.002993219980060582
sonography,0.002993219980060582
sp02,0.002993219980060582
specimens,0.002993219980060582
spermogram,0.002993219980060582
st,0.002993219980060582
expressed,0.002993219980060582
extracted,0.002993219980060582
hads,0.002993219980060582
hemagglutinins,0.002993219980060582
hematocrit,0.002993219980060582
adjudication,0.002993219980060582
true,0.002993219980060582
trv,0.002993219980060582
ulcerated,0.002993219980060582
ulceration,0.002993219980060582
unaffected,0.002993219980060582
unconsciousness,0.002993219980060582
demonstrated,0.002993219980060582
opioid,0.002993219980060582
microg,0.002993219980060582
minimize,0.002993219980060582
transformed,0.002993219980060582
transfused,0.002993219980060582
transthoracic,0.002993219980060582
transverse,0.002993219980060582
2009,0.002993219980060582
27,0.002993219980060582
corpuscular,0.002993219980060582
meaning,0.002993219980060582
parity,0.002993219980060582
pd1,0.002993219980060582
gonadic,0.002993219980060582
respect,0.002993219980060582
rest,0.002993219980060582
reticulocyte,0.002993219980060582
reviewed,0.002993219980060582
rnaemia,0.002993219980060582
failures,0.002993219980060582
fatigue,0.002993219980060582
febrile,0.002993219980060582
pneumonitis,0.002993219980060582
lost,0.002993219980060582
biobanking,0.002993219980060582
permanent,0.002993219980060582
persistence,0.002993219980060582
apparition,0.002993219980060582
brutal,0.002993219980060582
transferrin,0.002993219980060582
fecal,0.002993219980060582
ex,0.002993219980060582
expect,0.002993219980060582
expert,0.002993219980060582
standardized,0.002993219980060582
stevens,0.002993219980060582
ib,0.002993219980060582
cessation,0.002993219980060582
agreement,0.002993219980060582
possibly,0.002993219980060582
dilatation,0.002993219980060582
discontinue,0.002993219980060582
tomographic,0.002993219980060582
38c,0.002993219980060582
3mg,0.002993219980060582
lowest,0.002993219980060582
phenotypes,0.002993219980060582
droplet,0.002993219980060582
ebmt,0.002993219980060582
testosterone,0.002993219980060582
compute,0.002993219980060582
boulevard,0.002993219980060582
lee,0.002993219980060582
lh,0.002993219980060582
submitted,0.002993219980060582
subsequent,0.002993219980060582
substance,0.002993219980060582
suffering,0.002993219980060582
sum,0.002993219980060582
supervision,0.002993219980060582
estimates,0.002993219980060582
combining,0.002993219980060582
ileum,0.002993219980060582
intra,0.002993219980060582
kawasaki,0.002993219980060582
keratitis,0.002993219980060582
knowledge,0.002993219980060582
laboratoire,0.002993219980060582
ldh,0.002993219980060582
journal,0.002993219980060582
bvas,0.002993219980060582
called,0.002993219980060582
immunology,0.002993219980060582
immunomodulation,0.002993219980060582
resection,0.002993219980060582
reactivations,0.002993219980060582
reason,0.002993219980060582
immunophenotyping,0.002993219980060582
incidences,0.002993219980060582
record,0.002993219980060582
recoveries,0.002993219980060582
edge,0.002993219980060582
efficiency,0.002993219980060582
encephalitis,0.002993219980060582
swab,0.002993219980060582
progressive,0.002993219980060582
chapter,0.002993219980060582
comorbidities,0.002993219980060582
episodes,0.002993219980060582
5mg,0.002993219980060582
5ml,0.002993219980060582
72,0.002993219980060582
73m2,0.002993219980060582
80c,0.002993219980060582
amenorrhea,0.002993219980060582
cdai,0.002993219980060582
incorporating,0.002993219980060582
infiltrate,0.002993219980060582
ratios,0.002993219980060582
isolated,0.002993219980060582
intercurrent,0.002993219980060582
internal,0.002993219980060582
internet,0.002993219980060582
interruption,0.002993219980060582
questionaire,0.002993219980060582
alterations,0.002993219980060582
1mg,0.002993219980060582
neutrophiles,0.002993219980060582
normalized,0.002993219980060582
obtaining,0.002993219980060582
occlusive,0.002993219980060582
myocardial,0.002993219980060582
nausea,0.002993219980060582
necker,0.002993219980060582
dedicated,0.002993219980060582
cytogenetic,0.002993219980060582
walk,0.002993219980060582
crohns,0.002993219980060582
uti,0.002993219980060582
v1,0.002993219980060582
cytopenia,0.002993219980060582
vomiting,0.002993219980060582
vod,0.002993219980060582
variable,0.002993219980060582
variants,0.002993219980060582
1000,0.002993219980060582
109,0.0026243942074082914
120,0.0026243942074082914
vs,0.0026243942074082914
deciliter,0.0026243942074082914
decided,0.0026243942074082914
deaths,0.0026243942074082914
v4,0.0026243942074082914
upper,0.0026243942074082914
cross,0.0026243942074082914
nasal,0.0026243942074082914
myocarditis,0.0026243942074082914
objectives,0.0026243942074082914
alloimmunization,0.0026243942074082914
radiotherapy,0.0026243942074082914
question,0.0026243942074082914
joint,0.0026243942074082914
aminotransferase,0.0026243942074082914
inference,0.0026243942074082914
indicating,0.0026243942074082914
independence,0.0026243942074082914
85,0.0026243942074082914
eq5d,0.0026243942074082914
comorbidity,0.0026243942074082914
idiopathic,0.0026243942074082914
ptcy,0.0026243942074082914
proven,0.0026243942074082914
prospective,0.0026243942074082914
proportions,0.0026243942074082914
profiles,0.0026243942074082914
anxiety,0.0026243942074082914
targeting,0.0026243942074082914
sustained,0.0026243942074082914
ejection,0.0026243942074082914
efficient,0.0026243942074082914
ab,0.0026243942074082914
recovery,0.0026243942074082914
recherche,0.0026243942074082914
cd19,0.0026243942074082914
carried,0.0026243942074082914
important,0.0026243942074082914
reporting,0.0026243942074082914
illness,0.0026243942074082914
drop,0.0026243942074082914
c3,0.0026243942074082914
later,0.0026243942074082914
priapism,0.0026243942074082914
investigating,0.0026243942074082914
invasive,0.0026243942074082914
intravenously,0.0026243942074082914
colon,0.0026243942074082914
success,0.0026243942074082914
subpopulation,0.0026243942074082914
subgroups,0.0026243942074082914
storage,0.0026243942074082914
stopped,0.0026243942074082914
alanine,0.0026243942074082914
load,0.0026243942074082914
lines,0.0026243942074082914
lesion,0.0026243942074082914
blind,0.0026243942074082914
birads,0.0026243942074082914
dosage,0.0026243942074082914
times,0.0026243942074082914
thrombocytopenia,0.0026243942074082914
threshold,0.0026243942074082914
phenotyping,0.0026243942074082914
malignancies,0.0026243942074082914
42,0.0026243942074082914
discharge,0.0026243942074082914
died,0.0026243942074082914
development,0.0026243942074082914
conjugate,0.0026243942074082914
logmar,0.0026243942074082914
air,0.0026243942074082914
admission,0.0026243942074082914
ch50,0.0026243942074082914
explored,0.0026243942074082914
exploratory,0.0026243942074082914
experience,0.0026243942074082914
exclusion,0.0026243942074082914
approximately,0.0026243942074082914
applied,0.0026243942074082914
pharmacokinetics,0.0026243942074082914
binary,0.0026243942074082914
beneficial,0.0026243942074082914
longer,0.0026243942074082914
platform,0.0026243942074082914
plasmapheresis,0.0026243942074082914
rheumatoid,0.0026243942074082914
retinopathy,0.0026243942074082914
resistant,0.0026243942074082914
hospitalisation,0.0026243942074082914
hospitalier,0.0026243942074082914
hormonal,0.0026243942074082914
characterize,0.0026243942074082914
marker,0.0026243942074082914
medullar,0.0026243942074082914
medication,0.0026243942074082914
median,0.0026243942074082914
panel,0.0026243942074082914
contraindication,0.0026243942074082914
microalbuminuria,0.0026243942074082914
depending,0.0026243942074082914
tubes,0.0026243942074082914
corresponding,0.0026243942074082914
correlation,0.0026243942074082914
match,0.0026243942074082914
gold,0.0026243942074082914
saes,0.0026243942074082914
room,0.0026243942074082914
growth,0.0026243942074082914
spontaneous,0.0026243942074082914
sedimentation,0.0026243942074082914
saturation,0.0026243942074082914
sante,0.0026243942074082914
sampling,0.0026243942074082914
circulating,0.0026243942074082914
chose,0.0026243942074082914
chorioretinal,0.0026243942074082914
charlson,0.0026243942074082914
fixed,0.0026243942074082914
necrosis,0.0026243942074082914
oncology,0.0026243942074082914
basis,0.0026243942074082914
bacteria,0.0026243942074082914
avoid,0.0026243942074082914
autoantibodies,0.0026243942074082914
oxygen,0.0026243942074082914
osteonecrosis,0.0026243942074082914
minor,0.0026243942074082914
updated,0.0026243942074082914
details,0.0026243942074082914
monoclonal,0.0026243942074082914
authorization,0.0026243942074082914
atrial,0.0026243942074082914
aspartate,0.0026243942074082914
nephropathy,0.0026243942074082914
abnormality,0.0026243942074082914
abnormal,0.0026243942074082914
similarly,0.0026243942074082914
serological,0.0026243942074082914
clinique,0.0026243942074082914
fresh,0.0026243942074082914
fraction,0.0026243942074082914
2008,0.002323041608779928
ventilation,0.002323041608779928
note,0.002323041608779928
currently,0.002323041608779928
genetic,0.002323041608779928
future,0.002323041608779928
silent,0.002323041608779928
french,0.002323041608779928
2003,0.002323041608779928
cytokine,0.002323041608779928
role,0.002323041608779928
adaptive,0.002323041608779928
gr,0.002323041608779928
history,0.002323041608779928
respiratory,0.002323041608779928
hopital,0.002323041608779928
hypertension,0.002323041608779928
stay,0.002323041608779928
sarcoma,0.002323041608779928
screening,0.002323041608779928
eyes,0.002323041608779928
fully,0.002323041608779928
chemotherapy,0.002323041608779928
fish,0.002323041608779928
participant,0.002323041608779928
medicine,0.002323041608779928
attributed,0.002323041608779928
detailed,0.002323041608779928
pressure,0.002323041608779928
institut,0.002323041608779928
publique,0.002323041608779928
elderly,0.002323041608779928
initial,0.002323041608779928
programme,0.002323041608779928
bleeding,0.002323041608779928
answer,0.002323041608779928
known,0.002323041608779928
computed,0.002323041608779928
investigational,0.002323041608779928
team,0.002323041608779928
taking,0.002323041608779928
endemic,0.002323041608779928
especially,0.002323041608779928
erythrocyte,0.002323041608779928
rapidly,0.002323041608779928
rapid,0.002323041608779928
infarct,0.002323041608779928
analysed,0.002323041608779928
indexed,0.002323041608779928
induced,0.002323041608779928
immediate,0.002323041608779928
immunogenicity,0.002323041608779928
relative,0.002323041608779928
http,0.002323041608779928
require,0.002323041608779928
collect,0.002323041608779928
hgf,0.002323041608779928
aims,0.002323041608779928
detected,0.002323041608779928
binding,0.002323041608779928
developed,0.002323041608779928
pathology,0.002323041608779928
twice,0.002323041608779928
demonstrate,0.002323041608779928
design,0.002323041608779928
depression,0.002323041608779928
method,0.002323041608779928
overlap,0.002323041608779928
oral,0.002323041608779928
meet,0.002323041608779928
106,0.002323041608779928
authority,0.002323041608779928
occurring,0.002323041608779928
autoimmune,0.002323041608779928
mechanical,0.002323041608779928
correlated,0.002323041608779928
biomedical,0.002323041608779928
pharmacodynamic,0.002323041608779928
conventional,0.002323041608779928
continue,0.002323041608779928
context,0.002323041608779928
determine,0.002323041608779928
lupus,0.002323041608779928
bmt,0.002323041608779928
aplastic,0.002323041608779928
malignant,0.002323041608779928
limit,0.002323041608779928
release,0.0020682516170579318
surgery,0.0020682516170579318
starting,0.0020682516170579318
cyclophosphamide,0.0020682516170579318
given,0.0020682516170579318
concomitant,0.0020682516170579318
medications,0.0020682516170579318
overload,0.0020682516170579318
mds,0.0020682516170579318
therapies,0.0020682516170579318
louis,0.0020682516170579318
exposure,0.0020682516170579318
size,0.0020682516170579318
specified,0.0020682516170579318
source,0.0020682516170579318
review,0.0020682516170579318
adult,0.0020682516170579318
centre,0.0020682516170579318
residual,0.0020682516170579318
flow,0.0020682516170579318
sites,0.0020682516170579318
delayed,0.0020682516170579318
cycles,0.0020682516170579318
notably,0.0020682516170579318
obtained,0.0020682516170579318
cov2,0.0020682516170579318
withdrawal,0.0020682516170579318
selection,0.0020682516170579318
single,0.0020682516170579318
classic,0.0020682516170579318
significant,0.0020682516170579318
factor,0.0020682516170579318
family,0.0020682516170579318
hospitalizations,0.0020682516170579318
receiving,0.0020682516170579318
opinion,0.0020682516170579318
11,0.0020682516170579318
medium,0.0020682516170579318
mixed,0.0020682516170579318
appropriate,0.0020682516170579318
population,0.0020682516170579318
2012,0.0020682516170579318
2013,0.0020682516170579318
iron,0.0020682516170579318
kaposi,0.0020682516170579318
principal,0.0020682516170579318
isatuximab,0.0020682516170579318
therapeutic,0.0020682516170579318
testing,0.0020682516170579318
late,0.0020682516170579318
threatening,0.0020682516170579318
eligibility,0.0020682516170579318
inhibitor,0.0020682516170579318
ratio,0.0020682516170579318
report,0.0020682516170579318
subject,0.0020682516170579318
historical,0.0020682516170579318
ileal,0.0020682516170579318
higher,0.0020682516170579318
80,0.0020682516170579318
https,0.0020682516170579318
recommended,0.0020682516170579318
comparison,0.0020682516170579318
antibiotics,0.0020682516170579318
syndromes,0.0020682516170579318
term,0.0020682516170579318
double,0.0020682516170579318
plan,0.0020682516170579318
consent,0.0020682516170579318
major,0.0020682516170579318
33,0.0020682516170579318
concerning,0.0020682516170579318
pr,0.0020682516170579318
followed,0.0018475424871367764
signs,0.0018475424871367764
characteristics,0.0018475424871367764
sensitivity,0.0018475424871367764
groups,0.0018475424871367764
haplo,0.0018475424871367764
decision,0.0018475424871367764
france,0.0018475424871367764
reported,0.0018475424871367764
high,0.0018475424871367764
tnf,0.0018475424871367764
information,0.0018475424871367764
recommendations,0.0018475424871367764
70,0.0018475424871367764
conditioning,0.0018475424871367764
40,0.0018475424871367764
management,0.0018475424871367764
poor,0.0018475424871367764
benefit,0.0018475424871367764
met,0.0018475424871367764
outcome,0.0018475424871367764
multiple,0.0018475424871367764
available,0.0018475424871367764
ongoing,0.0018475424871367764
validated,0.0018475424871367764
unrelated,0.0018475424871367764
